+

ES3011359T3 - Adeno-associated viral vectors for treating myocilin (myoc) glaucoma - Google Patents

Adeno-associated viral vectors for treating myocilin (myoc) glaucoma Download PDF

Info

Publication number
ES3011359T3
ES3011359T3 ES21204257T ES21204257T ES3011359T3 ES 3011359 T3 ES3011359 T3 ES 3011359T3 ES 21204257 T ES21204257 T ES 21204257T ES 21204257 T ES21204257 T ES 21204257T ES 3011359 T3 ES3011359 T3 ES 3011359T3
Authority
ES
Spain
Prior art keywords
myoc
adeno
glaucoma
viral vectors
associated viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21204257T
Other languages
Spanish (es)
Inventor
Peter Pechan
Abraham Scaria
Jeffery Ardinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ES3011359T3 publication Critical patent/ES3011359T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES21204257T 2014-09-16 2015-09-16 Adeno-associated viral vectors for treating myocilin (myoc) glaucoma Active ES3011359T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462051229P 2014-09-16 2014-09-16

Publications (1)

Publication Number Publication Date
ES3011359T3 true ES3011359T3 (en) 2025-04-07

Family

ID=54238590

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21204257T Active ES3011359T3 (en) 2014-09-16 2015-09-16 Adeno-associated viral vectors for treating myocilin (myoc) glaucoma

Country Status (5)

Country Link
CA (1) CA2961523A1 (en)
ES (1) ES3011359T3 (en)
PL (1) PL4012035T3 (en)
PT (1) PT4012035T (en)
WO (1) WO2016044478A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3500676A4 (en) * 2016-08-16 2020-07-01 The University of North Carolina at Chapel Hill METHOD AND COMPOSITIONS FOR TARGETED GENE TRANSFER
JP2023520582A (en) * 2020-04-06 2023-05-17 アルナイラム ファーマシューティカルズ, インコーポレイテッド Compositions and methods for silencing MYOC expression
WO2022076711A2 (en) * 2020-10-07 2022-04-14 Regenxbio Inc. Adeno-associated viruses for ocular delivery of gene therapy
JP2024520740A (en) * 2021-06-03 2024-05-24 ダイノ セラピューティクス インコーポレイテッド Capsid variants and methods of using same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001523959A (en) 1997-04-21 2001-11-27 ユニバーシティ オブ フロリダ Materials and methods for ribozyme treatment of disease
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
ES2308989T3 (en) 1999-08-09 2008-12-16 Targeted Genetics Corporation INCREASE IN THE EXPRESSION OF A NUCLEOTIDIC SEQUENCE HETEROLOGY FROM RECOMBINANT VIRECT VECTORS CONTAINING A SEQUENCE FORMING INTRACATENARY BASE PAIRS.
ES2256265T3 (en) 2000-06-01 2006-07-16 University Of North Carolina At Chapel Hill DUVICATED PARVOVIRUS VECTORS.
SG10202108118RA (en) 2001-11-13 2021-08-30 Univ Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
GB0403600D0 (en) * 2004-02-18 2004-03-24 Trinity College Dublin Methods and reagents for treating disease
WO2005117938A2 (en) * 2004-04-13 2005-12-15 Regents Of The University Of Minnesota Methods of treating ocular conditions
US7765583B2 (en) 2005-02-28 2010-07-27 France Telecom System and method for managing virtual user domains
US8283151B2 (en) 2005-04-29 2012-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
WO2007120542A2 (en) 2006-03-30 2007-10-25 The Board Of Trustees Of The Leland Stanford Junior University Aav capsid library and aav capsid proteins
CA2694091A1 (en) * 2007-10-01 2009-04-09 Alcon Research, Ltd. Self complementary aav-mediated delivery of interfering rna molecules to treat or prevent ocular disorders
WO2009105690A2 (en) 2008-02-21 2009-08-27 Targeted Genetics Corporation Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
CN103502458B (en) 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

Also Published As

Publication number Publication date
PL4012035T3 (en) 2025-03-24
CA2961523A1 (en) 2016-03-24
WO2016044478A1 (en) 2016-03-24
PT4012035T (en) 2025-02-11

Similar Documents

Publication Publication Date Title
IL279154B (en) Adeno-associated virus vector
ZA201900945B (en) Methods for detecting aav
GB201401707D0 (en) Adeno-associated viral vectors
IL251178A0 (en) Adeno-associated viral vectors for treating myocilin (myoc) glaucoma
SI3145949T1 (en) Lentiviral vectors
EP3225730A4 (en) Washing apparatus
EP3153620A4 (en) Washing apparatus
DK3405290T3 (en) Centrifuge
PL3180897T3 (en) Throughput guidance based on user plane insight
SG11201702040WA (en) Mass spectrometer
GB201615417D0 (en) Fluoometric analyzer
PL3135381T3 (en) Centrifuge
ES3011359T3 (en) Adeno-associated viral vectors for treating myocilin (myoc) glaucoma
GB2566572B (en) Methods for adeno-associated viral vector production
GB2543719B (en) Spectrometer
PL3110557T3 (en) Centrifuge
GB2541346B (en) Mass spectrometer
PL3160652T3 (en) Centrifuge
GB201411243D0 (en) Swatch
AU2014904499A0 (en) Vector
GB201408419D0 (en) Universal inclined plane apparatus
GB201502660D0 (en) Hollyman(c)
GB201418108D0 (en) Rapid diagnostic test for viral infections
GB201416285D0 (en) Guidance Wizard
AU2014900078A0 (en) Alpaca parentage test
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载